P0803 Biosimilar Therapy in IBD: Real-World Evidence from Saudi Arabia
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjae190.0977
Abstract: Inflammatory Bowel Disease (IBD) is a chronic condition with increasing incidence, particularly in newly industrialized countries. The high cost of biologic treatments has led to the development of biosimilars like infliximab CT-P13, which offer a… read more here.
Keywords: clinical response; week; ibd; rates week ... See more keywords